EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 ATTENUATES THE GLYCAEMIC RESPONSE TO ENTERAL NUTRIENT IN CRITICALLY ILL PATIENTS WITH PRE-EXISTING TYPE-2 DIABETES MELLITUS

被引：0
|
作者：
Deane, A. [1 ,2 ]
Chapman, M. J. [1 ,2 ]
Fraser, R. J. [3 ]
Summers, M. J. [4 ]
Zaknic, A. V. [4 ]
DiBartolomeo, A. [2 ]
Horowitz, M. [3 ]
机构：
[1] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia
来源：
INTENSIVE CARE MEDICINE | 2010年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0346
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [31] INHIBITION OF GASTRIC-EMPTYING BY GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    WILLMS, B
    WERNER, J
    CREUTZFELDT, W
    ORSKOV, C
    HOLST, JJ
    NAUCK, M
    DIABETES, 1994, 43 : A230 - A230
  • [32] Evolutionary or revolutionary? The transformative role of glucagon-like peptide-1 agonists in type-2 diabetes management
    Bockwoldt, Denise
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 : S1 - S1
  • [33] Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients
    Renner, Eva
    Dora, Fanni
    Oszwald, Erzsebet
    Dobolyi, Arpad
    Palkovits, Miklos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [34] Cardioprotective properties of glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus patients: A systematic review
    Widiarti, Wynne
    Sukmajaya, Alverina Cynthia
    Nugraha, David
    Alkaff, Firas Farisi
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (03) : 837 - 843
  • [35] Glutamine Reduces Postprandial Glycemia and Augments the Glucagon-Like Peptide-1 Response in Type 2 Diabetes Patients
    Samocha-Bonet, Dorit
    Wong, Olivia
    Synnott, Emma-Leigh
    Piyaratna, Naomi
    Douglas, Ashley
    Gribble, Fiona M.
    Holst, Jens J.
    Chisholm, Donald J.
    Greenfield, Jerry R.
    JOURNAL OF NUTRITION, 2011, 141 (07): : 1233 - 1238
  • [36] Preserved Inhibitory Effect of Glucagon-Like Peptide-1 (GLP-1) on Glucagon Secretion in Type 2 Diabetes Mellitus
    Hare, Kristine J.
    Knop, Filip K.
    Asmar, Meena
    Larsen, Steen
    Madsbad, Sten
    Holst, Jens J.
    Vilsboll, Tina
    DIABETES, 2009, 58 : A372 - A372
  • [37] Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Hansen, K. B.
    Knop, F. K.
    Holst, J. J.
    Vilsboll, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (08) : 1154 - 1160
  • [38] Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients
    ten Kulve, Jennifer S.
    van Bloemendaal, Liselotte
    Balesar, Rawien
    IJzerman, Richard G.
    Swaab, Dick F.
    Diamant, Michaela
    la Fleur, Susanne E.
    Alkemade, Anneke
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (05): : 2122 - 2129
  • [39] Impaired Myocardial Response to Glucagon-Like Peptide 1 in Humans With Type 2 Diabetes Mellitus
    Moberly, Steven P.
    Hutchins, Gary D.
    Tune, Johnathan D.
    Perry, Kevin
    Chisholm, Robin L.
    Considine, Robert V.
    Mather, Kieren J.
    DIABETES, 2012, 61 : A475 - A475
  • [40] Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus
    Tsukamoto, Shunichiro
    Tanaka, Shohei
    Yamada, Takayuki
    Uneda, Kazushi
    Azushima, Kengo
    Kinguchi, Sho
    Wakui, Hiromichi
    Tamura, Kouichi
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 262 - 274
12345